Unique gene expression and clinical characteristics are associated with the 11q23 deletion in chronic lymphocytic leukaemia

British Journal of Haematology

Volumn 128, Issue 4, 2005, Pages 460-471

  Dickinson, John D ^a   Smith, Lynette M ^a   Sanger, Warren G ^a   Zhou, Guimei ^b   Townley, Peter ^c   Lynch, James C ^a   Pavletic, Z Steven ^d   Bierman, Philip J ^b   Joshi, Shantaram S ^a,e  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c Department of Pathology   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Chromosome 11q; Chronic lymphocytic leukaemia; CLL fish; Gene arrays

Indexed keywords

COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE 1; IMMUNOGLOBULIN HEAVY CHAIN; PROTEIN SERINE THREONINE KINASE;

ADULT; AGED; APOPTOSIS; ARTICLE; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HUMAN; MALE; MUTATION; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; TRISOMY 12; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; SIGNAL TRANSDUCTION;

EID: 14144254149     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05344.x     Document Type: Article

References (41)

1. Aalto, Y., El-Rifa, W., Vilpo, L., Ollila, J., Nagy, B., Vihinen, M., Vilpo, J. & Knuutila, S. (2001) Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion. Leukemia, 15, 1721-1728.
2. Aoun, P., Blair, H.E., Smith, L.M., Dave, B.J., Lynch, J., Weisenburger, D.D., Pavletic, Z.S. & Sanger, W.G. (2004) Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma. Leukemia and Lymphoma, 45, 1595-1603.
3. Boultwood, J. (2001) Ataxia telangiectasia gene mutations in leukaemia and lymphoma. Journal Clinical Pathology, 54, 512-516.
4. Byrd, J.C., Smith, L., Hackbarth, M.L., Flinn, I.W., Young, D., Proffitt, J.H. & Heerema, N.A. (2003) Interphase cytogenetic abnormalities in chronic lymphocytic leukemia may predict response to rituximab. Cancer Research, 63, 36-38.
5. Caligaris-Cappio, F. & Hamblin, T.J. (1999) B-cell chronic lymphocytic leukemia: a bird of a different feather. Journal of Clinical Oncology, 17, 399-408.
6. Chevallier, P., Penther, D., Avet-Loiseau, H., Robillard, N., Ifrah, N., Mahe, B., Hamidou, M., Maisonneuve, H., Moreau, P., Jardel, H., Harousseau, J.L., Bataille, R. & Garand, R. (2002) CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia. British Journal of Haematology, 116, 142-150.
7. Chiorazzi, N. & Ferrarini, M. (2003) B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annual Review of Immunology, 21, 841-894.
8. Criel, A., Verhoef, G., Vlietinck, R., Mecucci, C., Billiet, J., Michaux, L., Meeus, P., Louwagie, A., Van Orshoven, A., Van Hoof, A., Boogaerts, M., Van den Berghe, H. & De Wolf-Peeters, C. (1997) Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases. British Journal Haematology, 97, 383-391.
9. Cuneo, A., Bigoni, R., Rigolin, G.M., Roberti, M.G., Bardi, A., Piva, N., Milani, R., Bullrich, F., Veronese, M.L., Croce, C., Birg, F., Dohner, H., Hagemeijer, A. & Castoldi, G. (1999) Cytogenetic profile of lymphoma of follicle mantle lineage: correlation with clinicobiologic features. Blood, 93, 1372-1380.
10. Cuneo, A., Bigoni, R., Rigolin, G.M., Roberti, M.G., Milani, R., Bardi, A., Minotto, C., Agostini, P., De Angeli, C., Narducci, M.G., Sabbioni, S., Russo, G., Negrini, M. & Castoldi, G. (2000) Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: correlation with clinicobiologic features. Journal of Clinical Oncology, 18, 2607-2614.
11. Dai, Y., Dent, P. & Grant, S. (2002) Induction of apoptosis in human leukemia cells by the CDK1 inhibitor CGP74514A. Cell Cycle, 1, 143-152.
12. Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. & Chiorazzi, N. (1999) Ig V gene mutation Status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, 1840-1847.
13. Dewald, G.W., Brockman, S.R., Paternoster, S.F., Bone, N.D., O'Fallon, J.R., Allmer, C., James, C.D., Jelinek, D.F., Tschumper, R.C., Hanson, C.A., Pruthi, R.K., Witzig, T.E., Call, T.G. & Kay, N.E., (2003) Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia. British Journal Haematology, 121, 287-295.
14. Dohner, H., Fischer, K., Bentz, M., Hansen, K., Benner, A., Cabot, G., Diehl, D., Schlenk, R., Coy, J., Stilgenbauer, S., Volkmann, M., Galle, P., Poustka, A., Hunstein, W. & Lichter, P. (1995) p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood, 85, 1580-1589.
15. Dohner, H., Stilgenbauer, S., James, M., Benner, A. & Lichter, P. (1997) 11q Deletions identify a new subset of B-Cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood, 89, 2516-2522.
16. Dohner, H., Stilgenbauer, S., Dohner, K., Bentz, M. & Lichter, P. (1999) Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. Journal of Molecular Medicine, 77, 266-281.
17. Dohner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Krober, A., Bullinger, L., Dohner, K., Bentz, M. & Lichter, P. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. New England Journal of Medicine, 343, 1910-1916.
18. Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. & Stevenson, F.K. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood, 94, 1848-1854.
19. Haslinger, C., Schweifer, N., Stilgenbauer, S., Dohner, H., Lichter, P., Kraut, N., Stratowa, C. & Abseher, R. (2004) Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status. Journal of Clinical Oncology, 22, 3937-3949.
20. Heintel, D., Schwarzinger, I., Chizzali-Bonfadin, C., Thalhammer, R., Schwarzmeier, J., Fritzer-Szekeres, M., Weltermann, A., Simonitsch, I., Lechner, K. & Jaeger, U. (2001) Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia. Leukemia and Lymphoma, 42, 1315-1321.
21. Ito, Y., Yoshida, H., Matsuzuka, F., Matsuura, N., Nakamura, Y., Nakamine, H., Kakudo, K., Kuma, K. & Miyauchi, A. (2003) Cdc2 expression in primary thyroid lymphoma: its relationship with biological aggressiveness and G2 cyclins. Pathology Research Practice, 199, 533-538.
22. Jackman, M., Lindon, C., Nigg, E.A. & Pines, J. (2003) Active cyclin B1-Cdk1 first appears on centrosomes in prophase. Nature Cell Biology, 5, 143-148.
23. Jin, Y.H. & Park, C.K. (2002) Expression of cyclin B1 and cdc2 in nodal non-Hodgkin's lymphoma and its prognostic implications. Journal of Korean Medical Science, 17, 322-327.
24. Juliano, R. (2003) Movin' on through with Cdc2. Nature Cell Biology, 5, 589-590.
25. Kipps, T.J. (1997) Chronic lymphocytic leukemia. Current Opinion in Hematology, 4, 268-276.
26. Klein, U., Tu, Y., Stolovitzky, G.A., Mattioli, M., Cattoretti, G., Husson, H., Freedman, A., Inghirami, G., Cro, L., Baldini, L., Neri, A., Califano, A. & Dalla-Favera, R. (2001) Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. Journal of Experimental Medicine, 194, 1625-1638.
27. Krober, A., Seiler, T., Benner, A., Bullinger, L., Bruckle, E., Lichter, P., Dohner, H. & Stilgenbauer, S. (2002) V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood, 100, 1410-1416.
28. Mensink, E., van de Locht, A., Schattenberg, A., Linders, E., Schaap, N., Geurts van Kessel, A. & De Witte, T. (1998) Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR. British Journal of Haematology, 102, 768-774.
29. O'Brien, S., del Giglio, A. & Keating, M. (1995) Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. Blood, 85, 307-318.
30. Oscier, D.G., Matutes, E., Copplestone, A., Pickering, R.M., Chapman, R., Gillingham, R., Catovsky, D. & Hamblin, T.J.(1997) Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12. British Journal of Haematology, 98, 934-939.
31. Rosenwald, A., Alizadeh, A.A., Widhopf, G., Simon, R., Davis, R.E., Yu, X., Yang, L., Pickeral, O.K., Rassenti, L.Z., Powell, J., Botstein, D., Byrd, J.C., Grever, M.R., Cheson, B.D., Chiorazzi, N., Wilson, W.H., Kipps, T.J., Brown, P.O. & Staudt, L.M. (2001) Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. Journal Experimental Medicine, 194, 1639-1647.
32. Rosenwald, A., Wright, G., Wiestner, A., Chan, W.C., Connors, J.M., Campo, E., Gascoyne, R.D., Grogan, T.M., Muller-Hermelink, H.K., Smeland, E.B., Chiorazzi, M., Giltnane, J.M., Hurt, E.M., Zhao, H., Averett, L., Henrickson, S., Yang, L., Powell, J., Wilson, W.H., Jaffe, E.S., Simon, R., Klausner, R.D., Montserrat, E., Bosch, F., Greiner, T.C., Weisenburger, D.D., Sanger, W.G., Dave, B.J., Lynch, J.C., Vose, J., Armitage, J.O., Fisher, R.I., Miller, T.P., LeBlanc, M., Ott, G., Kvaloy, S., Holte, H., Delabie, J. & Staudt, L.M. (2003) The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell, 3, 185-197.
33. Shaughnessy, J., Jr, Tian, E., Sawyer, J., McCoy, J., Tricot, G., Jacobson, J., Anaissie, E., Zangari, M., Fassas, A., Muwalla, F., Morris, C. & Barlogie, B. (2003) Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy II. British Journal of Haematohgy, 120, 44-52.
34. Shiloh, Y. (2003) ATM and related protein kinases: safeguarding genome integrity. Nature Reviews Cancer, 3, 155-168.
35. Stilgenbauer, S., Liebisch, P., James, M.R., Schroder, M., Schlegelberger, B., Fischer, K., Bentz, M., Lichter, P. & Dohner, H. (1996) Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders. Proceedings of the National Academy of Science United States of America, 93, 11837-11841.
36. Stilgenbauer, S., Nickolenko, J., Wilhelm, J., Wolf, S., Weitz, S., Dohner, K., Boehm, T., Dohner, H. & Lichter, P. (1998) Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Oncogene, 16, 1891-1897.
37. Stilgenbauer, S., Lichter, P. & Dohner, H. (2002) Genetics of chronic lymphocytic leukemia: genomic aberrations and VH gene mutation status in pathogenesis and clinical course. Leukemia, 16, 993-1007.
38. Whitfield, M.L., Sherlock, G., Saldanha, A.J., Murray, J.I., Ball, C.A., Alexander, K.E., Matese, J.C., Perou, C.M., Hurt, M.M., Brown, P.O. & Botstein, D. (2002) Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Molecular Biology of the Cell, 13, 1977-2000.
39. Wiestner, A., Rosenwald, A., Barry, T., Wright, G., Davis, R., Henrickson, S., Zhao, H., Ibbotson, R., Orchard, J., Davis, Z., Stetler-Stevenson, M., Raffeld, M., Arthur, D., Marti, G., Wilson, W., Hamblin, T., Oscier, D. & Staudt, L.M. (2003) ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood, 101, 4944-4951.
40. Wolowiec, D., Benchaib, M., Pernas, P., Deviller, P., Souchier, C., Rimokh, R., Felman, P., Bryon, P.A. & Ffrench, M. (1995) Expression of cell cycle regulatory proteins in chronic lymphocytic leukemias. Comparison with non-Hodgkin's lymphomas and non-neoplastic lymphoid tissue. Leukemia, 9, 1382-1388.
41. Zakian, V.A. (1995) ATM-related genes: what do they tell us about functions of the human gene? Cell, 82, 685-687.